| Type | Public (NASDAQ: ISTA) |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1992 |
| Headquarters | Irvine, California |
| Key people |
Vicente Anido Jr., Ph.D., President, Chief Executive Officer, Glenn E. Davis, Vice President, Chief Compliance Officer, Marvin J. Garrett, Vice President, Regulatory Affairs, Quality & Compliance, Kathleen McGinley, Vice President, Human Resources & Corporate Services, Kirk McMullin, Vice President, Operations Timothy R. McNamara, PharmD, Vice President, Clinical Research & Medical Affairs Tom Mitro, Vice President, Sales & Marketing |
| Products | Bromday, Bepreve, Xibrom, Istalol, Vitrase |
| Website | http://www.istavision.com/ |
ISTA Pharmaceuticals, Inc, is a US based pharmaceutical company that specializes in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye.[1]